*ST生物
(000504)
| 流通市值：22.55亿 | | | 总市值：23.96亿 |
| 流通股本：3.11亿 | | | 总股本：3.30亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 22,453,576.28 | 134,447,796.85 | 92,417,062.87 | 56,324,793.65 |
| 营业收入 | 22,453,576.28 | 134,447,796.85 | 92,417,062.87 | 56,324,793.65 |
| 二、营业总成本 | 30,056,727.81 | 137,824,949.69 | 95,167,473.49 | 62,125,483.17 |
| 营业成本 | 7,867,087.84 | 43,808,006.11 | 29,542,541.68 | 19,622,847.34 |
| 税金及附加 | 173,796.99 | 1,230,450.71 | 638,144.98 | 438,460.7 |
| 销售费用 | 6,841,370.91 | 30,815,965.99 | 22,806,187.92 | 15,008,304.47 |
| 管理费用 | 12,350,768.52 | 52,516,614.3 | 35,380,862.61 | 23,075,248.2 |
| 研发费用 | 2,816,476.66 | 9,692,428.61 | 7,034,234.69 | 4,066,045.55 |
| 财务费用 | 7,226.89 | -238,516.03 | -234,498.39 | -85,423.09 |
| 其中:利息费用 | 233,956.99 | 1,462,451.13 | 1,243,069.12 | 817,173.7 |
| 其中:利息收入 | 294,442.31 | 2,026,910.01 | 1,694,435.21 | 1,067,435.86 |
| 加:公允价值变动收益 | -160,979 | -6,629 | -81,939 | -168,419 |
| 加:投资收益 | 1,578,281.89 | 3,689,457.92 | 2,089,486.36 | 444,037.19 |
| 资产处置收益 | -206.43 | 155,702.85 | -366,441.36 | - |
| 资产减值损失(新) | - | -471,202.67 | -1,961,313.37 | - |
| 信用减值损失(新) | 545,545.12 | -22,386,152.87 | -5,633,492.93 | -5,916,420.56 |
| 其他收益 | 86,540.89 | 1,581,972.5 | 1,247,493.37 | 382,265.02 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -5,553,969.06 | -20,814,004.11 | -7,456,617.55 | -11,059,226.87 |
| 加:营业外收入 | 1,592.92 | 212.71 | 212.69 | 212.69 |
| 减:营业外支出 | 380,307.33 | 37,815.78 | 18,845.68 | 6,806.37 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -5,932,683.47 | -20,851,607.18 | -7,475,250.54 | -11,065,820.55 |
| 减:所得税费用 | 589,376.71 | 3,073,995.13 | 1,410,564.82 | 563,351.83 |
| 六、净利润 | -6,522,060.18 | -23,925,602.31 | -8,885,815.36 | -11,629,172.38 |
| 持续经营净利润 | -6,522,060.18 | -23,925,602.31 | -8,885,815.36 | -11,629,172.38 |
| 归属于母公司股东的净利润 | -2,218,632.26 | -19,846,018.35 | -8,410,757.01 | -8,392,830.28 |
| 少数股东损益 | -4,303,427.92 | -4,079,583.96 | -475,058.35 | -3,236,342.1 |
| (一)基本每股收益 | -0.01 | -0.06 | -0.03 | -0.03 |
| (二)稀释每股收益 | -0.01 | -0.06 | -0.03 | -0.03 |
| 九、综合收益总额 | -6,522,060.18 | -23,925,602.31 | -8,885,815.36 | -11,629,172.38 |
| 归属于母公司股东的综合收益总额 | -2,218,632.26 | -19,846,018.35 | -8,410,757.01 | -8,392,830.28 |
| 归属于少数股东的综合收益总额 | -4,303,427.92 | -4,079,583.96 | -475,058.35 | -3,236,342.1 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-31 | 2024-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |